Want to join the conversation?
$CSCO 4Q15 Call: FY15 revenue was $49.2Bil, an increase of 4% vs. FY14. Returned $8.3Bil to shareholder through share buybacks and dividends in FY15, representing 73% of free cash flow. From geographic perspective, Americas grew 7%, EMEA decline 1% and APJC declined by 1%. Total emerging markets declined 2% with the BRIC plus Mexico down 7%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.